Cargando…

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age

Mostrar otras versiones (1)

Each novel SARS-CoV-2 variant renews concerns about decreased vaccine efficacy caused by evasion of vaccine induced neutralizing antibodies. However, accumulating epidemiological data show that while vaccine prevention of infection varies, protection from severe disease and death remains high. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bates, Timothy A., Lu, Pei, Kang, Ye jin, Schoen, Devin, Thornton, Micah, McBride, Savannah K., Park, Chanhee, Kim, Daehwan, Messer, William B., Curlin, Marcel E., Tafesse, Fikadu G., Lu, Lenette L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413715/ https://www.ncbi.nlm.nih.gov/pubmed/36032979 http://dx.doi.org/10.1101/2022.08.12.22278726

Ejemplares similares

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020)

Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020)

Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein
por: Visvabharathy, Lavanya, et al.
Publicado: (2023)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020)

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)

Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020)

SARSCoV-2 serostatus amongst vaccinated employees at a pediatric hospital system
por: Devaraj, Sridevi, et al.
Publicado: (2021)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Vaccination against SARSCoV-19 among psychiatric patients at the central Greek hospital
por: Anagnostaki, M. E., et al.
Publicado: (2023)

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
por: Bates, Timothy A., et al.
Publicado: (2022)

On the case report of Platypnea-orthodeoxia after SARSCoV-2 pneumonia plus historical notes
por: Corrêa, Paulo César Rodrigues Pinto
Publicado: (2020)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection
por: Lebrão, Cibele Wolf, et al.
Publicado: (2020)

Indian association of medical microbiologists (IAMM) position paper on guidelines for COVID and SARSCoV2 infections
por: Ravi, V., et al.
Publicado: (2023)

Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding
por: Slaats, Monique A.L.J., et al.
Publicado: (2020)

Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV- 2 vaccine Covaxin
por: Thakar, Meenakshi, et al.
Publicado: (2022)

495. De novo emergence of resistance mutations during treatment of SARSCoV-2 infection in immunocompromised patients
por: Johnson, Katherine, et al.
Publicado: (2023)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Immune transcriptomes of highly exposed SARSCoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
por: Lee, Hye Kyung, et al.
Publicado: (2020)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
por: Anupama, Y.J., et al.
Publicado: (2021)

Evolución temporal de las variantes de SARSCoV-2 circulantes en el área sanitaria de Cádiz
por: Ibañez-López, Cristina, et al.
Publicado: (2023)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
por: Cele, Sandile, et al.
Publicado: (2021)

The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction
por: Kobo, Ofer, et al.
Publicado: (2020)

Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients
por: Patrì, Angela, et al.
Publicado: (2021)

The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

Evaluation of neutralizing antibodies after vaccine BNT162b2: Preliminary data
por: Vietri, Maria Teresa, et al.
Publicado: (2022)

445 Inflammation in normal COVID-19 airway due to inhibition of cystic fibrosis transmembrane conductance regulator signaling by the SARSCoV-2 Spike protein
por: Caohuy, H., et al.
Publicado: (2022)

The Impact of COVID-19 on SARSCoV-2-Negative Elderly Patients with Hip Fractures: A Single-Center Retrospective Study from Shanghai, China
por: Zhao, Jinhui, et al.
Publicado: (2022)

Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2
por: McNulty, James, et al.
Publicado: (2023)

SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
por: Falsey, Ann R., et al.
Publicado: (2021)

Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation
por: Peled, Yael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_10bnq6asbd3kt5lj896est6mdc